NFE2L2 and prostate carcinoma: Given that Akt is overexpressed in prostate cancers [27] and that activated Akt promotes cell survival [28–29], to better understand the mechanism underpinning Nrf2 activation, we investigated the effects of TM treatment on Akt signaling pathway (Figure 2C).